Tobacco Giants Move Against E-Cigarettes as Conflicts of Interest Erupt

Today, the large tobacco company Altria Group announced its formal support for the FDA's regulations regarding vaping. This day has finally come; tobacco companies have ultimately taken action against e-cigarettes and expressed their stance. What hidden truths are behind all this?

Speaking of Altria, some may not be familiar, but the Philip Morris we often mention is actually a subsidiary of Altria, which owns brands like Marlboro and IQOS. This time, Altria has made a significant move to support the FDA's regulations, preparing to directly withdraw its e-cigarette products MarkTen Elite and Apex from the market!

Although Altria's e-cigarettes are not as popular as JUUL, they are still a notable part of the U.S. e-cigarette market. Many people are puzzled by Altria's actions; are they no longer profitable? Currently, the U.S. has legislation called "Tobacco 21," which prohibits citizens under 21 from purchasing tobacco products. It is reported that Ohio is also considering legislation called "Vapor 21," with similar legal effects. So, since there are already solutions to address youth vaping, why are they still so aggressively targeting vapes?
If we analyze the recent legal measures in the U.S., we can understand why large tobacco companies have intervened in the vaping issue at this time.

Aside from the aforementioned 21-year-old law, the most eye-catching is the FDA's plan to ban the sale of vapes in convenience stores. JUUL's market size surged significantly last year because it captured over 70% of the e-cigarette market share in convenience stores and gas stations.

Altria's appearance at this time may be due to the realization that the FDA finally has a measure that can significantly weaken the vape market! As a tobacco giant, they must have already realized that e-cigarettes, as the "new darling" of the tobacco industry, are significantly eating into their traditional cigarette market, and most importantly, affecting Altria's IQOS smoke-free future plan.

Earlier this year, Altria had already applied to the FDA for marketing authorization for IQOS, which has been classified as a cigarette! With this classification, Altria is now truly standing in opposition to vapes, and they are unafraid!
"Attack! Attack those vapes! After all, my main business is cigarettes! I don’t need my e-cigarettes anymore! No one can hinder my IQOS from selling well!"

Ultimately, this is a war of interests. The tobacco giants have long been planning to deal with e-cigarettes; they were just waiting for the right opportunity, and this time they are riding the wave of the FDA's trend. Moreover, don’t think these matters are merely verbal; in fact, JUUL has increased its spending on "lobbying" by 167% in the third quarter of this year to address various public relations issues. People fear what they do not understand!

Vapes, due to their functionality, fashionability, and excellent flavor profiles, have captivated many. However, as the saying goes, "the tall tree catches the wind," industries and companies affected by vapes are beginning to take action. Ultimately, this has evolved into a battle of interests in the U.S., leading to market chaos due to the country's circumstances. Harm reduction is beneficial to humanity, but in the end, it has turned into a war of interests. Where does this leave people's health?